Antiganglioside antibodies and their pathophysiological effects on Guillain-Barre syndrome and related disorders--A review
Open accessThe DOI matches its Crossref record; 226 of the 226 references it cites were found in a registry or an index.
Abstract
Guillain-Barré syndrome (GBS) is an acute immune-mediated polyradiculoneuropathy which can cause acute quadriplegia. Infection with micro-organisms, including Campylobacter jejuni (C. jejuni), Haemophilus influenzae, and Cytomegalovirus (CMV), is recognized as a main triggering event for the disease. Lipooligosaccharide (LOS) genes are responsible for the formation of human ganglioside-like LOS structures in infectious micro-organisms that can induce GBS. Molecular mimicry of LOSs on the surface of infectious agents and of ganglioside antigens on neural cells is thought to induce cross-reactive humoral and cellular immune responses. Patients with GBS develop antibodies against those gangliosides, resulting in autoimmune targeting of peripheral nerve sites, leading to neural damage. Heterogeneity of ganglioside expression in the peripheral nervous system (PNS) may underlie the differential clinical manifestation of the GBS variants. Recent studies demonstrate that some GBS sera react with ganglioside complexes consisting of two different gangliosides, such as GD1a and GD1b, or GM1 and GD1a, but not with each constituent ganglioside alone. The discovery of antiganglioside complex antibodies not only improves the detection rate of autoantibodies in GBS, but also provides a new concept in the antibody-antigen interaction through clustered carbohydrate epitopes. Although ganglioside mimicry is one of the possible etiological causes of GBS, unidentified factors may also contribute to the pathogenesis of GBS. While GBS is not considered a genetic disease, host factors, particularly human lymphocyte antigen type, appear to have a role in the pathogenesis of GBS following C. jejuni infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In the latter instance rare human immune responses against the ganglioside-like structures can even result in serious illness, with the complementfi xing antibodies damaging peripheral nerves (Guillain-Barré syndrome) (990 -991).”
From Biological roles of glycans (2017) · cites this paper as [991]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–226 of 226
Xiang, S.-L., Zhong, M., Cai, F. C., et al. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.02.009 · Cited by 17
Nakatani, Y., Nagaoka, T., Hotta, S., et al. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2006.11.015 · Cited by 17
Sugimoto, H., Wakata, N., Kishi, M., et al. (2002) · Journal of Neurology · doi:10.1007/s004150200018 · Cited by 16
Guillain-Barre syndrome in three siblings less than 2 years old.
Bar‐Joseph, G., Etzioni, A., Hemli, J., et al. (1991) · Archives of Disease in Childhood · doi:10.1136/adc.66.9.1078 · Cited by 16
Severe Guillain–Barré syndrome associated with chromosome 17p11.2‐12 duplication
Münch, C., Epplen, J. T., Meins, M., et al. (2007) · Muscle & Nerve · doi:10.1002/mus.20881 · Cited by 16
Human and chicken antibodies to gangliosides following infection by Campylobacter jejuni
Usuki, S., Taguchi, K., Cawthraw, S. A., Shibata, K., Ariga, T., Newell, D. G., & Yu, R. K. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.01.011 · Cited by 15
Self-citationGalNAc-GD1a is localized specifically in ventral spinal roots, but not in dorsal spinal roots
Yoshino, H., Utsunomiya, I., Taguchi, K., Ariga, T., Nagaoka, T., Aoyagi, H., Asano, A., Yamada, M., & Miyatake, T. (2005) · Brain Research · doi:10.1016/j.brainres.2005.07.063 · Cited by 15
Self-citationHLA antigens in familial Guillain-Barre syndrome.
Davidson, D. L., O'SULLIVAN, A. F., & Morley, K. D. (1992) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.6.508 · Cited by 14
Usuki, S., Pajaniappan, M., Thompson, S. A., & Yu, R. K. (2007) · Glycoconjugate Journal · doi:10.1007/s10719-006-9025-9 · Cited by 12
Self-citationRisk factors for Guillain-Barré syndrome: a population-based case-control study
D’Alessandro, R., Casmiro, M., & Guarino, M. (1999) · Journal of Neurology · doi:10.1007/s004150050504 · Cited by 11
Pandey, J. P., Koga, M., & Yuki, N. (2005) · Neurogenetics · doi:10.1007/s10048-005-0022-0 · Cited by 10
Okuda, B., Koga, M., Katsuta, T., et al. (2002) · Internal Medicine · doi:10.2169/internalmedicine.41.889 · Cited by 10
Misawa, N., Kawashima, K., Kondo, F., et al. (2001) · Journal of Endotoxin Research · doi:10.1177/09680519010070050201 · Cited by 10
CD1a and CD1e Allele Frequencies in an Italian Population from the Abruzzo Region
Aureli, A., Fontecchio, G., Altobelli, E., et al. (2007) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200702000225 · Cited by 10
Guillain-Barre Syndrome Associated with Legionnella Infection
Akyıldız, B. N., Gümüş, H., Kumandaş, S., et al. (2008) · Journal of Tropical Pediatrics · doi:10.1093/tropej/fmn010 · Cited by 9
Can Subdural Hematoma Be a Trigger for Guillain–Barré Syndrome?
Yardimci, N., Gülşen, S., Avcı, A. Y., et al. (2009) · International Journal of Neuroscience · doi:10.1080/00207450802480135 · Cited by 9
Vv, R., Mg, S., Reuben, S., et al. (2003) · PubMed · Cited by 9
Reuben, S., Mg, S., Mathai, A., et al. (2003) · PubMed · Cited by 8
Bullens, R. W. M., Halstead, S. K., O’Hanlon, G. M., et al. (2005) · Muscle & Nerve · doi:10.1002/mus.20327 · Cited by 8
Chatzipanagiotou, S., Kilidireas, K., Trimis, G. G., et al. (2003) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2003.00472.x · Cited by 6
Barium poisoning mimicking Guillain-Barre syndrome.
Talwar, V., Mehndiratta, N., & Verma, P. K. (2007) · PubMed · Cited by 6
Baravelli, M., Fantoni, C., Rossi, A., et al. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.11.033 · Cited by 4
Bidirectional transcription of lipooligosaccharide synthesis genes from Campylobacter jejuni
Phongsisay, V., & FRY, B. (2007) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2007.05.003 · Cited by 3
Condon, E. M., & Tobin, A. E. (2008) · Anaesthesia and Intensive Care · doi:10.1177/0310057x0803600516 · Cited by 3
Cann, S. A. H., Netten, J. P. V., & Netten, C. V. (2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200003)47:3
Price (1999) · doi:10.1002/1531-8249(199903)45:3
Research works printed but not linked: 2
- 101. Kusunoki S, Hitoshi S, Kaida K, Arita M, Kanazawa I. Monospecific anti-GD1b IgG is required to induce rabbit ataxic neuropathy. Ann Neurol. 1999;45:400–403. [[PubMed](https://pubmed.ncbi.nlm.nih.gov/10072058/)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Ann%20Neurol&title=Monospecific%20anti-GD1b%20IgG%20is%20required%20to%20induce%20rabbit%20ataxic%20neuropathy&author=S%20Kusunoki&author=S%20Hitoshi&author=K%20Kaida&author=M%20Arita&author=I%20Kanazawa&volume=45&publication_year=1999&pages=400-403&pmid=10072058&)] · doi:10.1002/1531-8249(199903)45:3<400::aid-ana19>3.0.co;2-y
- 159. Ropper AH, Wijdicks EFM, Truax B. Guillain-Barré Syndrome. Philadelphia, PA: FA Davis; 1991. pp. 117–118. [[Google Scholar](https://scholar.google.com/scholar_lookup?title=Guillain-Barr%C3%A9%20Syndrome&author=AH%20Ropper&author=EFM%20Wijdicks&author=B%20Truax&publication_year=1991&)]
Cited by
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
“In the latter instance rare human immune responses against the ganglioside-like structures can even result in serious illness, with the complement-fixing antibodies damaging peripheral nerves (Guillain-Barré syndrome) (990, 991).”
BackgroundStructures, Biosynthesis, and Functions of Gangliosides-an Overview
Yu, R. K., Tsai, Y.-T., Ariga, T., & Yanagisawa, M. (2011) · Journal of Oleo Science · doi:10.5650/jos.60.537 · Cited by 416
Self-citationEpidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome
Keddie, S., Pakpoor, J., Mousele, C., Pipis, M., Machado, P. M., Foster, M., Record, C. J., Keh, R. Y. S., Fehmi, J., Paterson, R. W., et al. (2021) · Brain · doi:10.1093/brain/awaa433 · Cited by 333
Metadata
- Authors
- Kaida, K., Ariga, T., & Yu, R. K.
- Affiliations
- Augusta University (US)
- ORCID
- Yu, R. K
- Venue
- Glycobiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-02-24
- Volume
- 19
- Issue
- 7
- Pages
- 676-692
- ISSN
- 0959-6658 (ISSN-L)
- 1460-2423
- PMC
- PMC2688390
- OpenAlex
- W2097643820
- Cited by
- 155
- References
- 226
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 3 · 2023: 11 · 2022: 14 · 2021: 9 · 2020: 16 · 2019: 11 · 2018: 4 · 2017: 4 · 2016: 9 · 2015: 5 · 2014: 8 · 2013: 4 · 2012: 10
- FWCI
- 1.57
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Glycobiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke (R01NS011853, R01NS026994, NS26994, NS-11 853)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Health Sciences › Medicine › Clinical Neurology › Autoimmune Neurological Disorders and Treatments
- Keywords
- Guillain-Barré syndrome, anti-ganglioside antibodies, gangliosides, lipooligosaccharide, molecular mimicry, Campylobacter jejuni, autoantibodies, GD1a, GM1, HLA, polyradiculoneuropathy, pathogenesis, infection-triggered autoimmunity
- MeSH terms
- Animals, Antigen-Antibody Reactions, Autoantibodies, Gangliosides, Humans, Lipopolysaccharides, Molecular Mimicry, Guillain-Barre Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.